InvestorsHub Logo
icon url

Mellowmood77

07/19/19 1:24 PM

#202381 RE: CalMustang #202377

I have a feeling they raised now because they will or are planning to file an amendment to the sNDA and get a 3 month delay which will drop this another 10-15 percent.

I don’t buy the “they did it for GS and JPMorgan” argument. This was calculated and planned as evidenced by the “coincidental” timing of 10b5-1 plans which SHOULD be investigated by the SEC. 365 days in a year and the plan executes near the all time high of the stock? It’s laughable. And criminal.

I did research on stocks delayed by the fda due to amendments and the announcement can come 5 days prior or 40.

The plus side? Most were approved after new PDUFA date. Some of them haven’t reached the new date yet.

Here is an extension that was announced FIVE days before PDUFA date.

https://www.globenewswire.com/news-release/2019/06/06/1865633/0/en/Xeris-Pharmaceuticals-Receives-Notification-of-PDUFA-Date-Extension-for-Gvoke.html
icon url

KCSVEN

07/19/19 1:36 PM

#202387 RE: CalMustang #202377

I think they pretty much did

"As part of the normal sNDA submission process"

Normal the key word there. I don't think this is an issue, if it was it would need to be disclosed with offering.
icon url

ggwpq

07/19/19 1:39 PM

#202389 RE: CalMustang #202377

Cal, thanks for asking. You are an asset to this board.